FDA Adverse Event Injury Summary report: N

PELVILACE TO BIOURETHRAL SUPPORT SYSTEM

MDR report key: 3223828 · Received July 10, 2013

Report

Report Number
1018233-2013-02756
Event Type
Injury
Date Received
July 10, 2013
Report Date
June 10, 2013
Manufacturer
TISSUE SCIENCE LABS
Product Code
FTL
PMA / PMN Number
K042949
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE EVENTS: "POTENTIAL COMPLICATIONS ASSOCIATED WITH THE PROPER IMPLANTATION OF THE PELVILACE TO SYSTEM MAY INCLUDE, BUT ARE NOT LIMITED TO: POSTOPERATIVE HEMATOMA, WHICH MAY OCCUR FOLLOWING THE IMPLANT PROCEDURE. TEMPORARY URINARY RETENTION, BLADDER OUTLET OBSTRUCTION, AND VOIDING DIFFICULTIES ASSOCIATED WITH OVER-CORRECTION/TOO MUCH TENSION PLACED ON THE IMPLANT. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER OR BOWEL, WHICH MAY OCCUR DURING NEEDLE PASSAGE. TRANSITORY IRRITATION AT THE OPERATIVE WOUND SITE, WHICH MAY ELICIT A FOREIGN BODY RESPONSE THAT LEADS TO INFLAMMATION, INFECTION, OR EROSION AT THE IMPLANT SITE." (B)(4).

Description of Event or Problem · 1

(B)(4). THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD'L INFO HAS BEEN REQUESTED, BUT NOT RECEIVED. ASSOCIATED MDRS: 1018233-2013-02757 AND 1018233-2013-02758.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
317687 PELVILACE TO BIOURETHRAL SUPPORT SYSTEM FTL TISSUE SCIENCE LABS NA CVSJ0016

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention LOT NUMBER: 08B02-1| PELVISOFT ACCELLULAR COLLAGEN BIOMESH: 481047| LOT NUMBER: 08B07-2| PELVISOFT ACCELLULAR COLLAGEN BIOMESH: 481812